Effects of risperidone and parent training on adaptive functioning in Children with Pervasive Developmental Disorders and serious behavioral problems

Lawrence Scahill, Christopher J. McDougle, Michael G. Aman, Cynthia Johnson, Benjamin Handen, Karen Bearss, James Dziura, Eric Butter, Naomi Swiezy, L. Eugene Arnold, Kimberly A. Stigler, Denis D. Sukhodolsky, Luc Lecavalier, Stacie L. Pozdol, Roumen Nikolov, Jill A. Hollway, Patricia Korzekwa, Allison Gavaletz, Arlene E. Kohn, Kathleen KoenigStacie Grinnon, James A. Mulick, Sunkyung Yu, Benedetto Vitiello

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Objective: Children with Pervasive Developmental Disorders (PDDs) have social interaction deficits, delayed communication, and repetitive behaviors as well as impairments in adaptive functioning. Many children actually show a decline in adaptive skills compared with age mates over time. Method: This 24-week, three-site, controlled clinical trial randomized 124 children (4 through 13 years of age) with PDDs and serious behavioral problems to medication alone (MED; n = 49; risperidone 0.5 to 3.5 mg/day; if ineffective, switch to aripiprazole was permitted) or a combination of medication plus parent training (PT) (COMB; n = 75). Parents of children in COMB received an average of 11.4 PT sessions. Standard scores and Age-Equivalent scores on Vineland Adaptive Behavior Scales were the outcome measures of primary interest. Results: Seventeen subjects did not have a post-randomization Vineland assessment. Thus, we used a mixed model with outcome conditioned on the baseline Vineland scores. Both groups showed improvement over the 24-week trial on all Vineland domains. Compared with MED, Vineland Socialization and Adaptive Composite Standard scores showed greater improvement in the COMB group (p =.01 and.05, and effect sizes = 0.35 and 0.22, respectively). On Age Equivalent scores, Socialization and Communication domains showed greater improvement in COMB versus MED (p =.03 and 0.05, and effect sizes = 0.33 and 0.14, respectively). Using logistic regression, children in the COMB group were twice as likely to make at least 6 months' gain (equal to the passage of time) in the Vineland Communication Age Equivalent score compared with MED (p =.02). After controlling for IQ, this difference was no longer significant. Conclusion: Reduction of serious maladaptive behavior promotes improvement in adaptive behavior. Medication plus PT shows modest additional benefit over medication alone. Clinical trial registration informationRUPP PI PDD: Drug and Behavioral Therapy for Children With Pervasive Developmental Disorders; http://www.clinicaltrials.gov; NCT00080145.

Original languageEnglish
Pages (from-to)136-146
Number of pages11
JournalJournal of the American Academy of Child and Adolescent Psychiatry
Volume51
Issue number2
DOIs
StatePublished - Feb 2012

Fingerprint

Risperidone
Socialization
Psychological Adaptation
Communication
Interpersonal Relations
Random Allocation
Problem Behavior
Randomized Controlled Trials
Parents
Logistic Models
Outcome Assessment (Health Care)
Clinical Trials
Drug Therapy

Keywords

  • adaptive behavior
  • children
  • parent training
  • pervasive developmental disorders
  • risperidone

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Developmental and Educational Psychology

Cite this

Effects of risperidone and parent training on adaptive functioning in Children with Pervasive Developmental Disorders and serious behavioral problems. / Scahill, Lawrence; McDougle, Christopher J.; Aman, Michael G.; Johnson, Cynthia; Handen, Benjamin; Bearss, Karen; Dziura, James; Butter, Eric; Swiezy, Naomi; Arnold, L. Eugene; Stigler, Kimberly A.; Sukhodolsky, Denis D.; Lecavalier, Luc; Pozdol, Stacie L.; Nikolov, Roumen; Hollway, Jill A.; Korzekwa, Patricia; Gavaletz, Allison; Kohn, Arlene E.; Koenig, Kathleen; Grinnon, Stacie; Mulick, James A.; Yu, Sunkyung; Vitiello, Benedetto.

In: Journal of the American Academy of Child and Adolescent Psychiatry, Vol. 51, No. 2, 02.2012, p. 136-146.

Research output: Contribution to journalArticle

Scahill, L, McDougle, CJ, Aman, MG, Johnson, C, Handen, B, Bearss, K, Dziura, J, Butter, E, Swiezy, N, Arnold, LE, Stigler, KA, Sukhodolsky, DD, Lecavalier, L, Pozdol, SL, Nikolov, R, Hollway, JA, Korzekwa, P, Gavaletz, A, Kohn, AE, Koenig, K, Grinnon, S, Mulick, JA, Yu, S & Vitiello, B 2012, 'Effects of risperidone and parent training on adaptive functioning in Children with Pervasive Developmental Disorders and serious behavioral problems', Journal of the American Academy of Child and Adolescent Psychiatry, vol. 51, no. 2, pp. 136-146. https://doi.org/10.1016/j.jaac.2011.11.010
Scahill, Lawrence ; McDougle, Christopher J. ; Aman, Michael G. ; Johnson, Cynthia ; Handen, Benjamin ; Bearss, Karen ; Dziura, James ; Butter, Eric ; Swiezy, Naomi ; Arnold, L. Eugene ; Stigler, Kimberly A. ; Sukhodolsky, Denis D. ; Lecavalier, Luc ; Pozdol, Stacie L. ; Nikolov, Roumen ; Hollway, Jill A. ; Korzekwa, Patricia ; Gavaletz, Allison ; Kohn, Arlene E. ; Koenig, Kathleen ; Grinnon, Stacie ; Mulick, James A. ; Yu, Sunkyung ; Vitiello, Benedetto. / Effects of risperidone and parent training on adaptive functioning in Children with Pervasive Developmental Disorders and serious behavioral problems. In: Journal of the American Academy of Child and Adolescent Psychiatry. 2012 ; Vol. 51, No. 2. pp. 136-146.
@article{0a48e8b897454e89b753144b170ef9cc,
title = "Effects of risperidone and parent training on adaptive functioning in Children with Pervasive Developmental Disorders and serious behavioral problems",
abstract = "Objective: Children with Pervasive Developmental Disorders (PDDs) have social interaction deficits, delayed communication, and repetitive behaviors as well as impairments in adaptive functioning. Many children actually show a decline in adaptive skills compared with age mates over time. Method: This 24-week, three-site, controlled clinical trial randomized 124 children (4 through 13 years of age) with PDDs and serious behavioral problems to medication alone (MED; n = 49; risperidone 0.5 to 3.5 mg/day; if ineffective, switch to aripiprazole was permitted) or a combination of medication plus parent training (PT) (COMB; n = 75). Parents of children in COMB received an average of 11.4 PT sessions. Standard scores and Age-Equivalent scores on Vineland Adaptive Behavior Scales were the outcome measures of primary interest. Results: Seventeen subjects did not have a post-randomization Vineland assessment. Thus, we used a mixed model with outcome conditioned on the baseline Vineland scores. Both groups showed improvement over the 24-week trial on all Vineland domains. Compared with MED, Vineland Socialization and Adaptive Composite Standard scores showed greater improvement in the COMB group (p =.01 and.05, and effect sizes = 0.35 and 0.22, respectively). On Age Equivalent scores, Socialization and Communication domains showed greater improvement in COMB versus MED (p =.03 and 0.05, and effect sizes = 0.33 and 0.14, respectively). Using logistic regression, children in the COMB group were twice as likely to make at least 6 months' gain (equal to the passage of time) in the Vineland Communication Age Equivalent score compared with MED (p =.02). After controlling for IQ, this difference was no longer significant. Conclusion: Reduction of serious maladaptive behavior promotes improvement in adaptive behavior. Medication plus PT shows modest additional benefit over medication alone. Clinical trial registration informationRUPP PI PDD: Drug and Behavioral Therapy for Children With Pervasive Developmental Disorders; http://www.clinicaltrials.gov; NCT00080145.",
keywords = "adaptive behavior, children, parent training, pervasive developmental disorders, risperidone",
author = "Lawrence Scahill and McDougle, {Christopher J.} and Aman, {Michael G.} and Cynthia Johnson and Benjamin Handen and Karen Bearss and James Dziura and Eric Butter and Naomi Swiezy and Arnold, {L. Eugene} and Stigler, {Kimberly A.} and Sukhodolsky, {Denis D.} and Luc Lecavalier and Pozdol, {Stacie L.} and Roumen Nikolov and Hollway, {Jill A.} and Patricia Korzekwa and Allison Gavaletz and Kohn, {Arlene E.} and Kathleen Koenig and Stacie Grinnon and Mulick, {James A.} and Sunkyung Yu and Benedetto Vitiello",
year = "2012",
month = "2",
doi = "10.1016/j.jaac.2011.11.010",
language = "English",
volume = "51",
pages = "136--146",
journal = "Journal of the American Academy of Child and Adolescent Psychiatry",
issn = "0890-8567",
publisher = "Elsevier Limited",
number = "2",

}

TY - JOUR

T1 - Effects of risperidone and parent training on adaptive functioning in Children with Pervasive Developmental Disorders and serious behavioral problems

AU - Scahill, Lawrence

AU - McDougle, Christopher J.

AU - Aman, Michael G.

AU - Johnson, Cynthia

AU - Handen, Benjamin

AU - Bearss, Karen

AU - Dziura, James

AU - Butter, Eric

AU - Swiezy, Naomi

AU - Arnold, L. Eugene

AU - Stigler, Kimberly A.

AU - Sukhodolsky, Denis D.

AU - Lecavalier, Luc

AU - Pozdol, Stacie L.

AU - Nikolov, Roumen

AU - Hollway, Jill A.

AU - Korzekwa, Patricia

AU - Gavaletz, Allison

AU - Kohn, Arlene E.

AU - Koenig, Kathleen

AU - Grinnon, Stacie

AU - Mulick, James A.

AU - Yu, Sunkyung

AU - Vitiello, Benedetto

PY - 2012/2

Y1 - 2012/2

N2 - Objective: Children with Pervasive Developmental Disorders (PDDs) have social interaction deficits, delayed communication, and repetitive behaviors as well as impairments in adaptive functioning. Many children actually show a decline in adaptive skills compared with age mates over time. Method: This 24-week, three-site, controlled clinical trial randomized 124 children (4 through 13 years of age) with PDDs and serious behavioral problems to medication alone (MED; n = 49; risperidone 0.5 to 3.5 mg/day; if ineffective, switch to aripiprazole was permitted) or a combination of medication plus parent training (PT) (COMB; n = 75). Parents of children in COMB received an average of 11.4 PT sessions. Standard scores and Age-Equivalent scores on Vineland Adaptive Behavior Scales were the outcome measures of primary interest. Results: Seventeen subjects did not have a post-randomization Vineland assessment. Thus, we used a mixed model with outcome conditioned on the baseline Vineland scores. Both groups showed improvement over the 24-week trial on all Vineland domains. Compared with MED, Vineland Socialization and Adaptive Composite Standard scores showed greater improvement in the COMB group (p =.01 and.05, and effect sizes = 0.35 and 0.22, respectively). On Age Equivalent scores, Socialization and Communication domains showed greater improvement in COMB versus MED (p =.03 and 0.05, and effect sizes = 0.33 and 0.14, respectively). Using logistic regression, children in the COMB group were twice as likely to make at least 6 months' gain (equal to the passage of time) in the Vineland Communication Age Equivalent score compared with MED (p =.02). After controlling for IQ, this difference was no longer significant. Conclusion: Reduction of serious maladaptive behavior promotes improvement in adaptive behavior. Medication plus PT shows modest additional benefit over medication alone. Clinical trial registration informationRUPP PI PDD: Drug and Behavioral Therapy for Children With Pervasive Developmental Disorders; http://www.clinicaltrials.gov; NCT00080145.

AB - Objective: Children with Pervasive Developmental Disorders (PDDs) have social interaction deficits, delayed communication, and repetitive behaviors as well as impairments in adaptive functioning. Many children actually show a decline in adaptive skills compared with age mates over time. Method: This 24-week, three-site, controlled clinical trial randomized 124 children (4 through 13 years of age) with PDDs and serious behavioral problems to medication alone (MED; n = 49; risperidone 0.5 to 3.5 mg/day; if ineffective, switch to aripiprazole was permitted) or a combination of medication plus parent training (PT) (COMB; n = 75). Parents of children in COMB received an average of 11.4 PT sessions. Standard scores and Age-Equivalent scores on Vineland Adaptive Behavior Scales were the outcome measures of primary interest. Results: Seventeen subjects did not have a post-randomization Vineland assessment. Thus, we used a mixed model with outcome conditioned on the baseline Vineland scores. Both groups showed improvement over the 24-week trial on all Vineland domains. Compared with MED, Vineland Socialization and Adaptive Composite Standard scores showed greater improvement in the COMB group (p =.01 and.05, and effect sizes = 0.35 and 0.22, respectively). On Age Equivalent scores, Socialization and Communication domains showed greater improvement in COMB versus MED (p =.03 and 0.05, and effect sizes = 0.33 and 0.14, respectively). Using logistic regression, children in the COMB group were twice as likely to make at least 6 months' gain (equal to the passage of time) in the Vineland Communication Age Equivalent score compared with MED (p =.02). After controlling for IQ, this difference was no longer significant. Conclusion: Reduction of serious maladaptive behavior promotes improvement in adaptive behavior. Medication plus PT shows modest additional benefit over medication alone. Clinical trial registration informationRUPP PI PDD: Drug and Behavioral Therapy for Children With Pervasive Developmental Disorders; http://www.clinicaltrials.gov; NCT00080145.

KW - adaptive behavior

KW - children

KW - parent training

KW - pervasive developmental disorders

KW - risperidone

UR - http://www.scopus.com/inward/record.url?scp=84855984767&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855984767&partnerID=8YFLogxK

U2 - 10.1016/j.jaac.2011.11.010

DO - 10.1016/j.jaac.2011.11.010

M3 - Article

C2 - 22265360

AN - SCOPUS:84855984767

VL - 51

SP - 136

EP - 146

JO - Journal of the American Academy of Child and Adolescent Psychiatry

JF - Journal of the American Academy of Child and Adolescent Psychiatry

SN - 0890-8567

IS - 2

ER -